Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Magnus Pfahl, Ph.D.

Maxia Pharmaceuticals # of Grants: 1

Grants

Analysis of Retinoid Mediated Anti-cancer Activities 1993 (Cycle 2) $757,415
Cancer Research Project Awards
Publications

Inhibition of estrogen receptor activity by the tumor promoter 12-O-Tetradeconylphorbol-13-Acetate: a molecular analysis
Periodical: Molecular Endocrinology Index Medicus:
Authors: Tzukerman M, Zhang XK, Pfahl M ART
Yr: 1991 Vol: 5 Nbr: 12 Abs: Pg: 1983-1992

Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
Periodical: Nature Index Medicus:
Authors: Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M ART
Yr: 1992 Vol: 355 Nbr: 6359 Abs: Pg: 441-446

Heterodimeric receptor complexes determine T3 and retinoid signaling specificities
Periodical: Molecular Endocrinology Index Medicus:
Authors: Hermann T, Hoffmann B, Zhang X-K, Tran P, Pfahl M ART
Yr: 1992 Vol: 6 Nbr: 7 Abs: Pg: 1153-1162

RARs and RXRalpha down-regulate the TGFbeta1 promoter by antagonizing AP-1 activity
Periodical: Molecular Endocrinology Index Medicus:
Authors: Salbert G, Fanjul A, Piedrafita FJ, et al ART
Yr: 1993 Vol: 7 Nbr: 10 Abs: Pg: 1347-1356

A novel class of retinoids with selective anti-AP-1 activity exhibit anti-proliferative activity
Periodical: Nature Index Medicus:
Authors: Fanjul A, Hobbs P, Graupner G, Zhang X-K, Dawson MI, Pfahl M ART
Yr: 1994 Vol: Nbr: Abs: Pg: